Several drug makers were handed an unexpected victory this week when a federal judge ruled they weren’t required to update product labels to warn about risks of pancreatic cancer with their diabetes medicines. In a 35-page ruling, US District Court Judge Anthony…
HEALTH EXCHANGE PLANS LIMIT PATIENT ACCESS TO HIV DRUGS
For the past two years, patient advocates have complained that many insurers are trying to discourage HIV patients from enrolling in policies sold on health insurance exchanges created by the Affordable Care Act. Now, a new analysis provides fresh evidence that…
Express scripts cuts off pharmacy that sells drugs for horizon pharma
In the latest fallout over the role that specialty pharmacies play in boosting prescription drug sales, Express Scripts has ended a contract with a company that is used by Horizon Pharma to distribute some of its medicines. Express Scripts cancelled its…
Pharmalot pharmalittle catching up on valeant, allergan, novartis
Hello, everyone, and how are you today? We are doing fine, thank you, especially given that this is the middle of the week. Perhaps you can relate. Of course, we will forge ahead, as always, since the alternatives appear bleak. This…
Drug makers kept many clinical trial results a secret
When it comes to disclosing clinical trial data, some drug makers are still keeping secrets, according to a new study. Thirty-five percent of all trial results for 15 drugs that were approved in 2012 by the Food and Drug Administration were…
Supreme court asked to review namenda product switching case
The US Supreme Court is weighing a request from Allergan to rule on whether drug companies can pull a medication from the market as generic competition looms in order to force patients to switch to new versions of the drug. The move, which may…